H. Frumin

发表

Arrhythmia control and other factors related to sudden death in coronary disease patients at intermediate risk.

M. Rubenfire, R. Blevins, N. Kerin, 1986, American heart journal.

Endless loop tachycardia started by an atrial premature complex in a patient with a dual chamber pacemaker.

H. Frumin, S. Furman, 1985, Journal of the American College of Cardiology.

ICD Implantation via Thoracoscopy without the Need for Sternotomy or Thoracotomy

H. Frumin, G. R. Goodman, M. Pleatman, 1993, Pacing and clinical electrophysiology : PACE.

The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope.

H. Calkins, F. Morady, Y. Shyr, 1995, The American journal of medicine.

Potentially Lethal Ventricular Arrhythmias: From Mundane to Esoteric

M. Rubenfire, N. Kerin, H. Frumin, 1989, Journal of clinical pharmacology.

Survival of Patients with Nonsustained Ventricular Tachycardia and Impaired Left Ventricular Function Treated with Low‐Dose Amiodarone

M. Rubenfire, N. Kerin, H. Frumin, 1991, Journal of clinical pharmacology.

Recurrent ventricular fibrillation in a marathon runner during exercise testing.

B. Franklin, W. O’Neill, H. Frumin, 2000, Chest.

Hemodynamic Effects of Antiarrhythmic Drugs

M. Rubenfire, N. Kerin, H. Frumin, 1991, Journal of clinical pharmacology.

A Low Incidence of Proarrhythmia Using Low-Dose Amiodarone

M. Rubenfire, R. Blevins, N. Kerin, 1988 .

Occlusion of a saphenous vein graft aneurysm with a vein-covered stent.

W. O’Neill, S. Dixon, H. Frumin, 2002, Journal of interventional cardiology.

Late thrombolysis of an occluded aortocoronary saphenous vein graft.

M. Rubenfire, H. Frumin, M. Goldberg, 1983, American heart journal.

Classification of Antiarrhythmic Drugs

M. Rubenfire, N. Kerin, H. Frumin, 1989, Journal of clinical pharmacology.

Two-dimensional echocardiographic detection and diagnostic features of tricuspid papillary fibroelastoma.

N. Kerin, H. Frumin, L. E. Nathan, 1983, Journal of the American College of Cardiology.

Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias.

M. Rubenfire, R. Blevins, N. Kerin, 1985, The American journal of cardiology.

Long‐term Efficacy and Toxicity of High‐ and Low‐Dose Amiodarone Regimens

N. Kerin, H. Frumin, K. Faitel, 1989, Journal of clinical pharmacology.

Protonation reactions at carbon sites in the anion radicals of certain unsaturated compounds and aromatic amino acids

H. Frumin, M. Sevilla, R. Failor, 1975 .

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.

Robert Lemery, M Huther, D Brill, 1992, The New England journal of medicine.

Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery.

W. O’Neill, H. Frumin, P. McCullough, 1999, American heart journal.

Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.

F. Morady, J. Hummel, C. Schuger, 2003, Journal of the American College of Cardiology.

Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study

P. H. Beadle, A. Skadsen, S. Swiryn, 2002 .

Mexiletine. Long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias.

M. Rubenfire, N. Kerin, H. Frumin, 1990, Archives of internal medicine.

Noncardiogenic pulmonary edema complicating massive verapamil overdose.

H. Frumin, M. Leesar, J. Talley, 1994, Chest.

Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience.

H. Frumin, K. Tobin, D. Westveer, 2000, The American journal of cardiology.

Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.

M. Rubenfire, R. Blevins, N. Kerin, 1988, Clinical cardiology.

Amiodarone in the management of refractory atrial fibrillation.

M. Rubenfire, R. Blevins, N. Kerin, 1987, Archives of internal medicine.

Treatment of underlying atrial fibrillation: paced rhythm obscures recognition.

H. Frumin, A. M. Patel, J. Stewart, 2000, Journal of the American College of Cardiology.

Prolonged Asystole During Head‐Up Tilt Table Testing After Beta Blockade

H. Frumin, R. Jarandilla, M. I. Dangovian, 1992, Pacing and clinical electrophysiology : PACE.

The Efficacy, Electrophysiologic and Electrocardiographic Effects of Intravenous Pirmenol, a New Class I Antiarrhythmic Agent, in Patients with Ventricular Tachycardia: Comparison with Procainamide *

C. Haffajee, N. Kerin, H. Frumin, 1988, Pacing and clinical electrophysiology : PACE.

Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study

P. H. Beadle, A. Skadsen, S. Swiryn, 2002 .

Mexiletine: Long-term Efficacy and Side Effects in Patients With Chronic Drug-Resistant Potentially Lethal Ventricular Arrhythmias

M. Rubenfire, N. Kerin, H. Frumin, 1990 .